90 (0.44/0.67), and 75 (0.16/0.91) ml/min/1.73 m 2 , respectively. Considering optimum thresholds for 10 modifiable risk factors, high-density lipoprotein cholesterol ^ 44 mg/dl ranked first; rankings for optimum renal function thresholds varied between sixth and tenth. Conclusions: Optimum eGFR thresholds for community-based risk triage were substantially higher than 60 ml/min/1.73 m 2 , which currently defines moderate abnormality. Utility of creatinine-based risk triage in older adults appears modest.
Introduction
As chronic kidney disease is widespread, usually silent, and associated with cardiovascular disease, it appears rational to question whether screening for renal dysfunction in community-dwelling adults would be useful, mirroring efforts regarding more familiar risk factors like lipids, blood pressure, body mass index, and blood glucose [1] [2] [3] . Before advocating screening with renal function measures for cardiovascular prevention, it would be useful to examine how different threshold levels predict the occurrence of future episodes of cardiovascular disease. Considered within finite intervals of follow-up, thresholds at which 'normal' values are associated with low cardiovascular event rates (high specificity) and 'abnormal' values with high rates (high sensitivity) might be useful from a public health perspective, especially with regard to intensity of follow-up and treatment of modifiable risk factors.
Regarding kidney function and cardiovascular events in the general population, much is unknown. For example, recognizing that gains in sensitivity are necessarily accompanied by losses in specificity, what threshold levels of serum creatinine and serum creatinine-based estimated glomerular filtration rate (eGFR) optimally separate people destined to develop cardiovascular events from those who are not? Which optimum kidney function threshold provides the greatest degree of discrimination? Are optimum threshold values the same in major demographic segments of the community? As declining kidney function tends to co-segregate with other classic cardiovascular risk factors, is it more efficient to screen for factors like lipid levels, body mass index, blood pressure, and blood glucose? In this long-term, communitybased study, a receiver operating characteristic approach [4] was used to identify thresholds with maximum sensitivity and specificity values, and classification tree methodology was used to assess the performance of serum creatinine, eGFR, and classic cardiovascular risk factors as discriminators of cardiovascular events and death.
Methods

Objectives
Regarding serum creatinine levels and eGFR calculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) [5] , Modification of Diet in Renal Disease (MDRD) Study [6] , and Cockcroft-Gault corrected for body surface area (CG/BSA) [7] equations in community-dwelling adults aged 45 to 64 years, the objectives of this study were as follows:
(1) To identify and compare threshold values of maximum combined sensitivity and specificity (Max Sn+Sp ) for predicting the composite outcome of coronary heart disease, stroke, or death;
(2) To perform analyses similar to those described in objective 1 for each of the separate components of the composite event;
(3) Based on Max Sn+Sp for the composite event, to use classification tree analysis to consider renal function thresholds in a framework that also considered classic cardiovascular risk factors, especially those recommended for screening in communitydwelling adults.
Subjects and Measurements
Detailed study information can be found at the Atherosclerosis Risk in Communities (ARIC) Study website [8] . ARIC is a prospective, longitudinal, community-based study of cardiovascular disease in four US communities [9] . Probability-based sampling methods were used in three of these communities (Forsyth County, N.C.; Washington County, Md.; Minneapolis, Minn.); in the fourth (Jackson, Miss.), driver's license and state identification card lists were used to select a representative group of AfricanAmerican residents. Baseline examinations were performed between 1987 and 1989 and repeated at 3-year intervals.
The population for this study consisted of participants with measured serum creatinine levels, 15,582 of the original 15,732 participants (99.0%). Serum creatinine levels, measured with the modified kinetic Jaffe-picric acid method from frozen serum samples at the ARIC central laboratory (University of Minnesota), were corrected for interlaboratory difference by subtraction of 0.24 mg/dl and standardized to the isotope dilution-mass spectrometry-traceable Roche enzymatic method by multiplication by 0.95 [10] [11] [12] . Body surface area was calculated from the formula of du Bois and du Bois [13] . Estimated GFR CKD-EPI (ml/min/ 1.73 m 2 ) was calculated from standardized serum creatinine (Scr, mg/dl) as follows [5] [7] . Hypertension was defined as systolic blood pressure 6 140 mm Hg, diastolic blood pressure 6 90 mm Hg, or current antihypertensive medication. Diabetes was defined by self-report, medication use, fasting blood glucose 6 126 mg/dl, or any blood glucose level 6 200 mg/dl. Baseline coronary heart disease was defined as physician-diagnosed history of heart attack, prior myocardial infarction by electrocardiogram, prior cardiovascular surgery, or coronary angioplasty.
Analysis
Median follow-up was 13.1 years. Cardiovascular event ascertainment methodology and validation findings have been published previously [14] . Coronary heart disease events were defined as probable myocardial infarction, definite myocardial infarction, silent myocardial infarction discovered by electrocardiography between examinations, death from definite coronary heart disease, or coronary revascularization. Hemorrhagic or thrombotic strokes were defined as probable or definite events. For this study, the main study outcome was a composite event defined by the earliest occurrence of coronary heart disease, stroke, or death.
Regarding the clinical outcomes, to identify Max Sn+Sp levels for Scr and eGFR at different thresholds (X), sensitivity (creatinine 1 X, eGFR ^ X among subjects with the event) and specificity (creatinine ^ X, eGFR 1 X among subjects without the event) were computed separately for thresholds that varied in 0.01 mg/l increments, between 0.5 and 2.0, for serum creatinine and in 1 ml/min/1.73 m 2 increments, between 50 and 120, for eGFR; only Max Sn+Sp levels with p ! 0.05 with logistic regression were considered valid.
Several subgroup analyses and sensitivity analyses were performed. As the discriminatory power of renal parameters might reflect associations with demographic or classic cardiovascular risk factors, we constructed a classification tree for the composite outcome based on the highest Max Sn+Sp value when all variables were considered simultaneously, with the additional proviso of p ! 0.05, for association with the composite outcome, using logistic regression. Renal variables were handled as detailed in the preceding paragraph; for other continuous variables, thresholds were changed in one-unit increments in the following ranges: age, 46-63 years; pack-years of smoking, 1-60; alcohol intake, 25-250 g/ week; body mass index (calculated as kg/m 2 ), 20-40; low-density lipoprotein (LDL) cholesterol, 70-200 mg/dl; high-density lipoprotein (HDL) cholesterol, 30-80 mg/dl; triglycerides, 50-250 mg/dl; glucose, 85-170 mg/dl; systolic blood pressure, 90-150 mm Hg; diastolic blood pressure, 60-100 mm Hg. The first two iterations of this process were used to define six subgroups based on Max Sn+Sp values for association with the composite outcome. In addition, subgroups were defined by sex, race, and presence of characteristics typically associated with renal dysfunction, namely diabetes, hypertension, or coronary heart disease. This study examined event occurrence at any time during the follow-up period, without considering time to event. Findings were similar when follow-up was truncated at 5 and 10 years, and are not reported here. Additionally, the classification tree approach was extended to five orders of dichotomization, generating 32 terminal subgroups. Terminal subgroups were then used to classify the entire population and both logistic regression and Cox regression were used to calculate risk ratios for the composite event; risk ratios with all strategies were very were similar and only findings based on the first iteration of the classification tree and logistic regression are reported here. SAS, version 9.1 (SAS Institute Inc., Cary, N.C., USA) was used for data analysis.
Results
The mean age of the study population (ARIC, n = 15,582) was 54.2 years; 55.1% were women and 26.4% were African-American ( table 1 ) . Mean standardized creatinine value was 0.83 mg/dl. Mean eGFR values were 95.7 ml/min/1.73 m 2 using the CKD-EPI estimating equation (eGFR CKD-EPI ) [5] , 98.6 ml/min/1.73 m 2 using the MDRD Study estimating equation (eGFR MDRD ) [6] , and 99.7 ml/min/1.73 m 2 using the Cockcroft-Gault corrected for body-surface area estimating equation (eGFR CG/BSA ) [7] .
The median follow-up was 13.1 years. During this period, 12.7% of the study population experienced a coronary heart disease event, 4.1% experienced a stroke, 13.3% died, and 22.1% experienced a composite of at least one of these events (the primary study outcome). Receiver operator characteristic curves for associations between serum creatinine, eGFR, and the composite outcome are shown in figure 1 ; c-statistic values were highest for serum creatinine (0.60), followed by eGFR CKD-EPI (0.57), eGFR CG/BSA (0.57), and eGFR MDRD (0.54). Corresponding c-statistics for the individual components of the composite outcome are shown in table 2 . For coronary heart disease, values were 0.62 for serum creatinine, 0.58 for eGFR CKD-EPI , 0.56 for eGFR CG/BSA , and 0.56 for eGFR MDRD . For cerebrovascular accident, values were 0.57 for serum creatinine, 0.55 for eGFR CG/BSA , 0.54 for eGFR CKD-EPI , and 0.50 for eGFR MDRD . For death, values were 0.59 for eGFR CG/BSA , 0.58 for serum creatinine, 0.57 for eGFR CKD-EPI , and 0.53 for eGFR MDRD .
Regarding associations with the composite outcome, figure 2 shows sensitivity and specificity values of different renal function thresholds for the composite outcome, and MDRD thresholds, and relatively higher specificity than sensitivity for eGFR MDRD .
We also calculated c-statistic values for association with the composite outcome in subgroups defined by demographic characteristics, and in subgroups defined by dominant prognostic association (data not shown). Findings generally paralleled findings in the overall popu lations, with approximately similar performance of serum creatinine, eGFR CKD-EPI , and eGFR CG/BSA , and inferior performance of eGFR MDRD . Regarding thresholds of Max Sn+Sp , values were typically higher than 60 ml/min/1.73 m 2 for eGFR and below 1.0 for serum creatinine. 
Discussion
In this community-based study of older adults, we found that creatinine-based thresholds exhibiting maximum combined sensitivity and specificity values for predicting cardiovascular events and death rates were substantially higher than 60 ml/min/1.73 m 2 , with the latter threshold distinguished by very low sensitivity and high specificity. In addition, we found that optimum thresholds based on serum creatinine appeared to perform similarly to eGFR thresholds. Regarding eGFR thresholds, those based on the MDRD Study formula appeared less efficient than those based on the other formulas. Finally, threshold renal function measures did not appear to be the dominant prognostic discriminators in the overall population or in the subgroups assessed. If confirmed, these findings suggest that creatinine-based estimates may not be very useful for prognostic triage and, by extension, that routine measurement in community-dwelling adults may not be an efficient strategy for predicting these diseases. The analytical approach used in this study was based on an effort to identify measures and thresholds of kidney function that outperformed competing renal and non-renal candidate variables. Selection of a dominant entity was based on the mathematical construct of maximum combined sensitivity and specificity values. Hence, risk factor prevalence weighed heavily into the selection process. Because this approach is hierarchical, it allows comparisons of different threshold values of a single risk factor; in addition, it facilitates comparisons of optimum threshold values of multiple risk factors. Both these attributes might be useful for risk-based triage in public health settings. This study suggests that even valid tests of kidney function have modest sensitivity for predicting cardiovascular events and death. This is not surprising, given the complex etiologies of these conditions.
Associations between kidney function, cardiovascular disease, and death have been studied extensively. For example, a PubMed search of human studies carried out in September 2010 with the search terms mortality or survival or cardiovascular, and glomerular filtration rate or creatinine or chronic kidney disease, and community or general population yielded 2,156 citations, a value that fell to 140 with the addition of 'sensitivity and specificity' and to four with the addition of 'threshold', with none of these four articles directly relevant to the questions addressed in the current study. Hence, it appears that few studies have attempted to define threshold levels of kidney function that maximally discriminate between occurrence, or not, of major cardiovascular events over finite intervals. One exception was an examination of 50-year-old Swedish men, in which optimum creatinine clearance thresholds for myocardial infarction and cardiovascular death were 98 and 92 ml/ min/1.73 m 2 , respectively [15] . Our group recently reported mortality-kidney function profiles from US adults studied between 1988 and 1994 in the third National Health and Nutrition Examination Survey (NHANES) [16] . The optimum eGFR CKD-EPI threshold for death/survival discrimination, 94 ml/min/1.73 m 2 , was similar to the threshold seen in the current study, and the optimum urinary albumin-creatinine ratio, 9 mg/g, was substantially lower than the thresholds used to define abnormality in most classification systems. Unlike in this study, the albumin-creatinine ratio and eGFR appeared to compare favorably with other classic risk factors for risk triage. A limitation of the previous study was nonavailability of most components of major adverse cardiovascular end points, such as coronary heart disease and stroke; in addition, optimally discriminatory serum creatinine thresholds were not studied. The reasons underlying the disparity in discriminatory efficiency of renal function measures between the two studies are not clear. This being said, it is tempting to speculate that the age bands studied (all adults in NHANES, ages 45-65 years in ARIC) may be partly responsible. In this regard, it is also tempting to speculate that the nonsuperior mortality discrimination of eGFR over serum creatinine also reflects the comparatively narrow age distribution of the study population.
The limitations of the current study deserve consideration. Findings were generated from four populations in the US between 1987 and 1989 and generalizability to other populations is uncertain. Gold-standard techniques, such as inulin and radioisotope clearance, were not available for GFR measurement. Urinary protein excretion information was not available. As with virtually all studies reported to date, kidney function in this study was measured on one occasion. In clinical practice, an eGFR or serum creatinine test suggesting the presence of chronic kidney disease would require a confirmatory test, as current guidelines for case finding suggest that abnormalities should be present for at least 3 months for case definition [17] . This study was based on a single assessment of GFR. As GFR values vary substantially from one time point to another, it is conceivable that sensitivity values may be higher if a strategy of multiple GFR assessments had been used.
Despite its limitations, this study has some attractive features. The study was community based and designed to be broadly representative. Several commonly used risk triage measures, such as cholesterol, blood pressure, and body mass index were systematically collected at the same time that renal function was measured, and a single creatinine measurement technique was used. While confirmation is needed, this study suggests that optimum thresholds for risk identification are higher than the value currently used to define a moderately abnormal GFR (60 ml/min/1.73 m 2 ). The utility of creatinine-based risk triage in older adults in community settings appears modest.
